Citadel Advisors - EPIRUS BIOPHARMACEUTICALS IN ownership

EPIRUS BIOPHARMACEUTICALS IN's ticker is EPRSQ and the CUSIP is 29428P107. A total of 41 filers reported holding EPIRUS BIOPHARMACEUTICALS IN in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of EPIRUS BIOPHARMACEUTICALS IN
ValueSharesWeighting
Q1 2016$28,000
-37.8%
10,359
-28.7%
0.00%
Q4 2015$45,000
-80.4%
14,535
-64.0%
0.00%
Q2 2015$230,00040,3830.00%
Other shareholders

There were no reported owners of EPIRUS BIOPHARMACEUTICALS IN in Q2 2015.

NameSharesValueWeighting ↓
View complete list of EPIRUS BIOPHARMACEUTICALS IN shareholders